These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21334334)

  • 21. Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR.
    Liddle C; Goodwin B
    Semin Liver Dis; 2002; 22(2):115-22. PubMed ID: 12016543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor.
    Fang Y; Hegazy L; Finck BN; Elgendy B
    J Med Chem; 2021 Dec; 64(24):17545-17571. PubMed ID: 34889100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptors in nonalcoholic Fatty liver disease.
    López-Velázquez JA; Carrillo-Córdova LD; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    J Lipids; 2012; 2012():139875. PubMed ID: 22187655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
    Gadaleta RM; van Mil SW; Oldenburg B; Siersema PD; Klomp LW; van Erpecum KJ
    Biochim Biophys Acta; 2010 Jul; 1801(7):683-92. PubMed ID: 20399894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear receptors and bone.
    Margolis RN
    Ann N Y Acad Sci; 2007 Nov; 1116():327-34. PubMed ID: 17872399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear receptors in regenerating liver and hepatocellular carcinoma.
    Vacca M; Degirolamo C; Massafra V; Polimeno L; Mariani-Costantini R; Palasciano G; Moschetta A
    Mol Cell Endocrinol; 2013 Apr; 368(1-2):108-19. PubMed ID: 22789748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.
    Mulder J; Karpen SJ; Tietge UJ; Kuipers F
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2599-630. PubMed ID: 19273222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [FXR and its influence on hepatobiliary and gastrointestinal diseases].
    Xu YJ; Zhao C; Yin YR
    Sheng Li Ke Xue Jin Zhan; 2013 Dec; 44(6):420-4. PubMed ID: 24665740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights on the xenobiotic-sensing nuclear receptors in liver diseases--CAR and PXR--.
    Kakizaki S; Yamazaki Y; Takizawa D; Negishi M
    Curr Drug Metab; 2008 Sep; 9(7):614-21. PubMed ID: 18781913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.
    di Masi A; De Marinis E; Ascenzi P; Marino M
    Mol Aspects Med; 2009 Oct; 30(5):297-343. PubMed ID: 19427329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARs and LXRs: atherosclerosis goes nuclear.
    Barish GD; Evans RM
    Trends Endocrinol Metab; 2004; 15(4):158-65. PubMed ID: 15109614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orphan nuclear receptor modulators.
    Mohan R; Heyman RA
    Curr Top Med Chem; 2003; 3(14):1637-47. PubMed ID: 14683519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
    Wang H; LeCluyse EL
    Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
    Gong H; Xie W
    Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometriosis and nuclear receptors.
    Yilmaz BD; Bulun SE
    Hum Reprod Update; 2019 Jul; 25(4):473-485. PubMed ID: 30809650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FXR, a multipurpose nuclear receptor.
    Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
    Rudraiah S; Zhang X; Wang L
    Annu Rev Pharmacol Toxicol; 2016; 56():605-626. PubMed ID: 26738480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.